KKKarl Kodeda

Karl Kodeda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karl Kodeda has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Time trends, improvements and national auditing of rectal cancer management over an 18‐year period

    by K. Kodeda, R. Johansson, N. Zar, H. Birgisson, M. Dahlberg, S. Skullman, G. Lindmark, B. Glimelius, L. Påhlman, A. Martling

    Aim: The main aims were to explore time trends in the management and outcome of patients with rectal cancer in a national cohort and to evaluate the possible impact of national auditing on overall outcomes. A secondary aim was to provide population‐based data for appraisal of external validity in selected patient series.Method: Data from the Swedish ColoRectal Cancer Registry with virtually complete national coverage were utilized in this cohort study on 29 925 patients with rectal cancer diagnosed between 1995 and 2012. Of eligible patients, nine were excluded.Results: During the study period, overall, relative and disease‐free survival increased. Postoperative mortality after 30 and 90 days decreased to 1.7% and 2.9%. The 5‐year local recurrence rate dropped to 5.0%. Resection margins improved, as did peri‐operative blood loss despite more multivisceral resections being performed. Fewer patients underwent palliative resection and the proportion of non‐operated patients increased. The proportions of temporary and permanent stoma formation increased. Preoperative radiotherapy and chemoradiotherapy became more common as did multidisciplinary team conferences. Variability in rectal cancer management between healthcare regions diminished over time when new aspects of patient care were audited.Conclusion: There have been substantial changes over time in the management of patients with rectal cancer, reflected in improved outcome. Much indirect evidence indicates that auditing matters, but without a control group it is not possible to draw firm conclusions regarding the possible impact of a quality control registry on faster shifts in time trends, decreased variability and improvements. Registry data were made available for reference.


  • Open Access

    A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

    by Elinor Bexe Lindskog, Katrín Ásta Gunnarsdóttir, Kristoffer Derwinger, Yvonne Wettergren, Bengt Glimelius, Karl Kodeda

    The value of adjuvant chemotherapy in colorectal cancer is well studied, and guidelines have been established. Little is known about how treatment guidelines are implemented in the everyday clinical setting.


  • Open Access

    A survey of surgeons’ perception and awareness of intraoperative time utilization

    by Sofia Erestam, Annette Erichsen, Kristoffer Derwinger, Karl Kodeda

    Surgical teams’ awareness of the time needed to perform specific phases of a surgical procedure is likely to improve communication in the operating theatre and benefit patient safety. The aim of this study was to assess surgeons’ awareness of time utilization and the actual time needed to perform specific phases of an operation.


  • Population-based data from the Swedish Colon Cancer Registry

    by K. Kodeda, L. Nathanaelsson, B. Jung, H. Olsson, P. Jestin, A. Sjövall, B. Glimelius, L. Påhlman, I. Syk

    Background: Evaluating the external validity of clinical trials requires knowledge not only of the study population but also of a relevant reference population. The main aim of this study was to present data from a large, contemporary, population-based cohort of patients with colonic cancer. Methods: Data on patients diagnosed between 2007 and 2011 were extracted from the Swedish Colon Cancer Registry. The data, registered prospectively in a national population of almost 10 million, included over 99 per cent of all diagnosed adenocarcinomas of the colon. Results: This analysis included 18 889 patients with 19 526 tumours (3·0 per cent had synchronous tumours). The sex distribution was fairly equal, and the median age was 74·1 (interquartile range 65–81) years. The overall and relative (cancer-specific) survival rates after 3 years were 62·7 and 71·4 per cent respectively. Some 88·0 per cent of the patients were operated on, and 83·8 per cent had tumours resected. Median blood loss during bowel resection was 200 (mean 311) ml, and the median operating time was 160 min; 5·6 per cent of the procedures were laparoscopic. Preoperative chemotherapy was administered to 2·1 per cent of patients; postoperative chemotherapy was planned in 90·1 per cent of fit patients aged less than 75 years with stage III disease. In patients operated on in an emergency setting (21·5 per cent), the preoperative evaluation was less extensive, the proportion of R0 resections was lower, and the outcomes were poorer, in both the short and long term. Conclusion: These population-based data represent good-quality reference points.


  • Commentary on Rondelli et al

    by Karl Kodeda

  • Genomic CGH-assessed structural DNA alterations in rectal carcinoma as related to local recurrence following primary operation for cure

    by K. Kodeda, A. Gustafsson Asting, C. Lönnroth, K. Derwinger, Y. Wettergren, S. Nordgren, B. Gustavsson, K. Lundholm

    Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications


  • Local recurrence of rectal cancer: a population‐based cohort study of diagnosis, treatment and outcome

    by K. Kodeda, K. Derwinger, B. Gustavsson, S. Nordgren

    Aim  Local recurrence is an important endpoint of rectal cancer treatment, but details of this form of treatment failure are less well described. The aim of this study was to acquire deeper knowledge of local recurrence regarding symptoms, diagnostic work‐up, clinical management, health‐care utilization and outcome.Method  Of 671 patients with rectal cancer, 57 were diagnosed with local recurrence within 5 years after surgery. Their records were analysed.Results  At diagnosis of local recurrence 49 (86%) of 57 patients were symptomatic and 40 (70%) were diagnosed between scheduled follow‐up visits. The predominant symptom was pain. Forty‐five of the 57 (79%) had a palpable tumour. Most were deemed incurable at presentation and 10 (18%) were operated on with curative intent. Five years after the initial rectal cancer surgery, two patients were alive, with one free of disease. Despite the need for multiple interventions, including surgery, only four out of 40 patients were classified as being well‐palliated in the terminal stage.Conclusion  Follow‐up after rectal cancer surgery by annual clinical examination is not sufficient to detect local recurrence when it is asymptomatic. Local recurrence of rectal cancer is often associated with intractable symptoms. These patients require frequent interventions and can rarely be cured if diagnosed at an advanced stage. Strategies for early detection of local recurrence and the management thereof require improvement.


  • Open Access

    Rectal washout and local recurrence of cancer after anterior resection

    by K Kodeda, E Holmberg, F Jörgren, S Nordgren, G Lindmark

    Adenocarcinomas of the rectum shed viable cells, which have the ability to implant. Intraoperative rectal washout decreases the amount and viability of these cells, but there is no conclusive evidence of the effect of rectal washout on local recurrence after rectal cancer surgery. Data were analysed from a population-based registry of patients who had anterior resection from 1995 to 2002 and were followed for 5 years. Rectal washout was performed at the discretion of the surgeon. National inclusion of patients with rectal cancer and follow-up was near complete (approximately 97 and 98 per cent respectively). A total of 4677 patients were analysed (3749 who had washout, 851 no washout and 77 with information missing); 52·0 per cent of patients in the washout group and 41·4 per cent in the no-washout group had preoperative radiotherapy (P < 0·001). Local recurrence rates were 6·0 and 10·2 per cent respectively (P < 0·001). Univariable and multivariable logistic regression analyses produced odds ratios that favoured washout: 0·56 (95 per cent confidence interval (c.i.) 0·43 to 0·72) and 0·61 (0·46 to 0·80) respectively (both P < 0·001). In multivariable analysis restricted to patients who had curative surgery, the odds ratio was 0·59 (95 per cent c.i. 0·44 to 0·78; P < 0·001). There was a more favourable outcome in patients after rectal washout than without.